MOVEMENT-DISORDERS ASSOCIATED WITH WITHDRAWAL FROM HIGH-DOSE INTRAVENOUS HALOPERIDOL THERAPY IN DELIRIOUS ICU PATIENTS

Intravenous haloperidol is recommended as the drug of choice to treat delirium in ICU patients. Movement disorders and other adverse events commonly occur with oral haloperidol use but are rarely seen with IV h aloperidol use, and withdrawal symptoms have not been reported with sh ort-term ICU use, We describe self-limited dyskinesia Juring withdrawa l of high-dose continuous IV haloperidol therapy in five ICU patients.